Medical Devices

Image

North America Throat Cancer Diagnostics Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Published Report
  • Feb 2023
  • North America
  • 350 Pages
  • No of Tables: 111
  • No of Figures: 47

North America Throat Cancer Diagnostics Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 716.67 Million
Diagram Market Size (Forecast Year) USD 1305.24 Million
Diagram CAGR %

North America Throat Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others), Distribution Channel (Direct Tender and Retail Sales) - Industry Trends and Forecast to 2030.

North America Throat Cancer Diagnostics Market Analysis and Insights

Increasing awareness about throat cancer has enhanced the market demand. The rising healthcare expenditure for better health services also contributes to the market's growth. The major market players focus on various service launches and approvals during this crucial period.

North America Throat Cancer Diagnostics Market

North America Throat Cancer Diagnostics Market

North America throat cancer diagnostics market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.8% in the forecast period of 2023 to 2030 and is expected to reach USD 1,305.24 million by 2030 from USD 716.67 million in 2022.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customisable to 2020-2015)

Quantitative Units

Revenue in USD Million

Segments Covered

By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others), Distribution Channel (Direct Tender and Retail Sales)

Countries Covered

U.S., Canada, Mexico

Market Players Covered

F. Hoffmann-La Roche Ltd., FUJIFILM Corporation, Thermo Fisher Scientific Inc., CANON MEDICAL SYSTEMS CORPORATION, Koninklijke Philips N.V., Merck KGaA, BD, General Electric Company, Illumina, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Abbott, QIAGEN, Siemens Healthcare GmbH, Myriad Genetics Inc., Quest Diagnostics Incorporated, Hologic, FONAR Corp., Time Medical Holding., MinFound Medical Systems Co., Ltd, and PlexBio among others

Market Definition

Throat cancer is a type of cancer that forms in tissues of the pharynx (the hollow tube inside the neck that starts behind the nose and ends at the top of the windpipe and esophagus). Throat cancer includes cancer of the nasopharynx (the upper part of the throat behind the nose), the oropharynx (the middle part of the pharynx), and the hypopharynx (the bottom part of the pharynx). Cancer of the larynx (voice box) may also be included as a type of throat cancer. Most throat cancers are squamous cell carcinomas (cancer that begins in thin, flat cells that look like fish scales), also called pharyngeal cancer.

North America Throat Cancer Diagnostics Market Dynamics

Drivers

  • Growing prevalence of throat cancer

Throat cancer is the second most common type of leukemia diagnosed in adults and children, but most cases occur in adults. Although it can be diagnosed at any age, it is uncommon before age 45. The average age of diagnosis is age 68. The rising use of cigarettes and other tobacco substitutes may be partially responsible for the rise in the prevalence of throat cancer.

People affected with throat cancer can see the symptoms such as a cough, changes in their voice, such as hoarseness or not speaking clearly, difficulty swallowing, ear pain, a lump or sore that doesn't heal, a sore throat, and weight loss among others.

  • Novel technological advancements in throat cancer diagnostics

Radiotherapy has an integral role in the treatment of throat cancer. Although radiotherapy has the potential to cure patients with advanced diseases, it also carries the potential for significant long-term morbidity. New technologies in the setting of head and neck radiotherapy are emerging, which have the potential to increase the cure rate and decrease toxicity. These new technologies include improved radiotherapy treatment design (intensity-modulated radiation therapy) and improved planning and implementation (image-guided radiation therapy).

Restraints

  • Late diagnosis and poor prognosis of throat cancer

Cancer is the leading cause of death worldwide. By 2030, it is anticipated that there will be 13.1 million more cancer-related deaths per year. However, if they are identified early on and given the right care, some cancers can be cured. The diagnostic process may experience delays in cancer diagnosis. When patients overlook or fail to respond to potentially cancerous signs, the late patient diagnosis will lead to the growth of cancerous tissue, worsening the cancer condition. The main cause of delayed presentation is a lack of public knowledge of early cancer signs, especially if such symptoms are unusual.

Thus, the late diagnosis often results from these factors, which result in poor prognosis. Thus, these are expected to restrain the growth of the North America throat cancer diagnostics market.

High cost for the installation of diagnostic devices

Cancer diagnostics have become increasingly expensive due to the growing number of throat cancer patients and the rising prices of medical devices. The modern technological devices used in cancer diagnosis also play a significant role in the high prices of cancer diagnostics, providing a definitive diagnosis for cancer in thyroid nodules with high accuracy. Therefore, the high cost of diagnostics procedures for throat cancers is hampering the market's growth.

The diagnostic products or devices which are used in the detection of cancer are becoming advanced. However, the procedure for cancer diagnostics is also costly, which hampers the growth of the throat cancer diagnostics market because the devices used in the process of cancer diagnosis are getting more expensive for the early detection of cancerous tissue, which results in to increase in the cost of diagnostics procedure.

Opportunities

  • Rise in healthcare expenditure for cancer diagnosis and treatment

Across the globe, research and development activities are escalating owing to the public health expenditure with economic performances. Rising healthcare expenditure could result in better provision of research and development opportunities. It is anticipated to increase the demand for throat diagnostics. Increasing the healthcare expenditure for cancer treatment also helps the patient take hassle-free advanced diagnostics and treatment for fast recovery. The spending on healthcare is made up of the combination of out-of-pocket payments (people paying for their care), government expenditure, and various sources such as different healthcare schemes published by the government in different regions. It also includes health insurance and activities by non-governmental organizations. This increasing healthcare expenditure for cancer treatment is an opportunity for the market's demand.

  • Government initiatives toward cancer diagnostics

The government plays a major role while taking the initiative for cancer diseases because cancer is a leading disease worldwide. Throat cancer has increased very rapidly in individuals in past decades. Throat cancer is the most prevalent cancer, with estimated 410,376 people new cases in 2022, according to cancer.gov.

There are several initiatives taken by the government that helps boost the market's demand, and these initiatives will increase awareness among people regarding their health and take early diagnosis for better cure and precaution. Growing healthcare expenditure is also beneficial for further economic growth and healthcare sector growth, and it is primarily fruitful as it significantly affects the development of better and advanced therapeutic options with various diagnostics products.

Challenges

  • Increased cost, safety, and convenience issues

Throat cancer is fatal, and the diagnosis process of this type of cancer also has safety issues. It is also not cost-effective. One of the most costly medical disorders to treat globally is cancer. Cancer patients may be hospitalized and receive a variety of therapies, such as surgery, radiation therapy, and systemic therapy. Health insurance premiums for cancer patients are now more expensive than in the past. In addition, their co-payment, deductible, and coinsurance costs are rising.

Rising helium shortage and rising risk of excessive radiation exposure are projected to restrict the use of CT scanners, threatening the possibilities of rising capital investments and low benefit-cost ratio for biomarkers. Many hospitals in developing countries cannot invest in diagnostic imaging equipment, which has led to increased use of reconstructed diagnostic imaging due to high expenditures and financial restrictions.

Recent Developments

  • In August 2022, F. Hoffmann-La Roche Ltd, announced the launch of the Digital LightCycler System, Roche's first digital polymerase chain reaction (PCR) system. This next-generation system detects disease and is designed to accurately quantify trace amounts of specific DNA and RNA targets not typically detectable by conventional PCR methods. This has helped the company to increase its North America presence in the market
  • In March 2021, Hologic, Inc. announced that the company had acquired Diagenode, a privately held Globalan developer and manufacturer of molecular diagnostic assays and epigenetics products. This further strengthens the molecular diagnostics business in the North America market

North America Throat Cancer Diagnostics Market Scope

The North America throat cancer diagnostics market is segmented into product type, test type, cancer type, stages, age group, end user, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

  • Instruments
  • Consumables & accessories

On the basis of product type, the North America throat cancer diagnostics market is segmented into instruments and consumables & accessories.

Test Type

  • Imaging Test
  • Blood Test
  • Biopsy
  • Others

On the basis of test type, the North America throat cancer diagnostics market is segmented into imaging test, blood test, biopsy, and others.

Cancer Type

  • Pharyngeal cancer
  • Laryngeal cancer

On the basis of cancer type, the North America throat cancer diagnostics market is segmented into pharyngeal cancer and laryngeal cancer.

Stages

  • Stage 0
  • Stage I
  • Stage II
  • Stage III
  • Stage IV

On the basis of stages, the North America throat cancer diagnostics market is segmented into stage 0, stage I, stage II, stage III, and stage IV.

Age Group

  • 30-65
  • 65 and above
  • 21-29
  • Below 21

On the basis of age group, the North America throat cancer diagnostics market is segmented into 30-65, 65 and above, 21-29, and below 21.

End User

  • Hospitals
  • Associated labs
  • Independent diagnostic laboratories
  • Diagnostic imaging centers
  • Cancer research institutes
  • Others

On the basis of end user, the North America throat cancer diagnostics market is segmented into hospitals, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others.

Distribution Channel

  • Direct tender
  • Retail sales

On the basis of distribution channel, the North America throat cancer diagnostics market is segmented into direct tender and retail sales.

North America Throat Cancer Diagnostics Market Regional Analysis/Insights

The North America throat cancer diagnostics market is analysed, and market size insights and trends are provided by country, product type, test type, cancer type, stages, age group, end user, and distribution channel, as referenced above.

The U.S. is expected to dominate the North America throat cancer diagnostics market due to the high prevalence of throat cancer in the region, and rapid research development is boosting the market.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of North America brands and their challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Throat Cancer Diagnostics Market Share Analysis

The North America throat cancer diagnostics market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the company’s focus on the North America throat cancer diagnostics market.

Some of the major players operating in the North America throat cancer diagnostics market are F. Hoffmann-La Roche Ltd., FUJIFILM Corporation, Thermo Fisher Scientific Inc., CANON MEDICAL SYSTEMS CORPORATION, Koninklijke Philips N.V., Merck KGaA, BD, General Electric Company, Illumina, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Abbott, QIAGEN, Siemens Healthcare GmbH, Myriad Genetics Inc., Quest Diagnostics Incorporated, Hologic, FONAR Corp., Time Medical Holding., MinFound Medical Systems Co., Ltd, and PlexBio among others.


SKU-

TABLE 1 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 2 NORTH AMERICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 NORTH AMERICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 4 NORTH AMERICA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA CONSUMABLES AND ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 12 NORTH AMERICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 13 NORTH AMERICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 14 NORTH AMERICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 15 NORTH AMERICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 16 NORTH AMERICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 17 NORTH AMERICA OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 18 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)

TABLE 19 NORTH AMERICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 20 NORTH AMERICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)

TABLE 21 NORTH AMERICA LARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA STAGE III IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA STAGE II IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA STAGE IV IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA STAGE I IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA STAGE 0 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA 30-65 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA 65 AND ABOVE IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA 21-29 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA BELOW 21 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 34 NORTH AMERICA HOSPITAL IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 35 NORTH AMERICA ASSOCIATED LABS IN THROAT CANCER DIAGNOSTICS MARKET, 2021-2030 (USD MILLION)

TABLE 36 NORTH AMERICA INDEPENDENT DIAGNOSTIC LABORATORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 37 NORTH AMERICA DIAGNOSTIC IMAGING CENTERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 NORTH AMERICA CANCER RESEARCH INSTITUTES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 NORTH AMERICA OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 41 NORTH AMERICA DIRECT TENDER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 NORTH AMERICA RETAIL SALES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 43 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 44 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 45 NORTH AMERICA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 46 NORTH AMERICA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 47 NORTH AMERICA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 48 NORTH AMERICA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 49 NORTH AMERICA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 50 NORTH AMERICA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 51 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 52 NORTH AMERICA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 53 NORTH AMERICA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 54 NORTH AMERICA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 55 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)

TABLE 56 NORTH AMERICA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)

TABLE 57 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)

TABLE 58 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 59 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 60 NORTH AMERICA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 61 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 62 U.S. INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 63 U.S. PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 U.S. IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 65 U.S. CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 66 U.S. KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 67 U.S. REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 68 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 69 U.S. IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 70 U.S. BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 71 U.S. BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 72 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)

TABLE 73 U.S. PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)

TABLE 74 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)

TABLE 75 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 76 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 77 U.S. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 78 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 79 CANADA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 80 CANADA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 CANADA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 82 CANADA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 CANADA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 84 CANADA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 85 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 86 CANADA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 87 CANADA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 88 CANADA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 89 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)

TABLE 90 CANADA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)

TABLE 91 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)

TABLE 92 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 93 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 94 CANADA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 95 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 96 MEXICO INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 97 MEXICO PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 98 MEXICO IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 99 MEXICO CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 100 MEXICO KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 101 MEXICO REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 102 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 103 MEXICO IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 104 MEXICO BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 105 MEXICO BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 106 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)

TABLE 107 MEXICO PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION)

TABLE 108 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION)

TABLE 109 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)

TABLE 110 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 111 MEXICO THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The North America Throat Cancer Diagnostics Market is projected to grow at a CAGR of 7.8% during the forecast period by 2030.
The future market value of the North America Throat Cancer Diagnostics Market is expected to reach USD 1,305.24 million by 2030.
The major players in the North America Throat Cancer Diagnostics Market are F. Hoffmann-La Roche Ltd., Abbott., Illumina, QIAGEN, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Inc. Merck KGaA., Hologic, Inc., General Electric Company, Siemens Healthcare GmbH, etc.
The countries covered in the North America Throat Cancer Diagnostics Market are U.S., Canada, Mexico.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials